The New Delhi-based Ranbaxy Laboratories on Thursday announced that it had got approval from the US drug authorities to market a paediatric dose of its generic version of Augmentin, GlaxoSmithKline
Stocks Waiting For The News
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 21 2003 | 12:00 AM IST
